US 6,888,000 B2 · Sulfonamide and sulfamide substituted imidazoquinolines

Abstract

Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain sulfonamide or sulfonamide functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.

Claims1

Dependent claims

The compound 1-(2-amino-2-methylpropyl)-2-(ethoxymethyl)-1H-imidazo[4,5-c]quinoline-4-amine, or a pharmaceutically acceptable salt thereof.

Dependencies are inferred from the claim text.

Facts

Application

10/734,306Filed 12 Dec 2003 · continuation

Priority

21 Dec 2001

Published

US 2004/0106638 A18 Jul 2004

Granted

3 May 2005

Term ends

Not estimatedThe source records don’t support an estimate.

Classification8 codes

A61K 31/4745
Ortho- or peri-condensed with heterocyclic ring systems: condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
A61P 37/02
Drugs for immunological or allergic disorders: immunomodulators
C07D 471/04
In which the condensed system contains two hetero rings: ortho-condensed systems
Y02A 50/30
In human health protection, e.g. against extreme weather: against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne…

Family

Application10/027,273Parent of this continuation · filed 21 Dec 2001

Application10/425,054Parent of this continuation · filed 28 Apr 2003

Application10/669,051Parent of this continuation · filed 23 Sep 2003

US 2004/0132762 A1Pre-grant publication · published 8 Jul 2004

US 6,677,349 B1Parent of this continuation

US 2004/0106638 A1Published application

US 6,924,293 B2Related patent

US 6,888,000 B2This patent

From the US filing history. Foreign family members aren’t listed.

Abstract

Facts

Application

10/734,306Filed 12 Dec 2003 · continuation

Priority

21 Dec 2001

Published

US 2004/0106638 A18 Jul 2004

Granted

3 May 2005

Term ends

Not estimatedThe source records don’t support an estimate.

Classification8 codes

A61K 31/4745
Ortho- or peri-condensed with heterocyclic ring systems: condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
A61P 37/02
Drugs for immunological or allergic disorders: immunomodulators
C07D 471/04
In which the condensed system contains two hetero rings: ortho-condensed systems
Y02A 50/30
In human health protection, e.g. against extreme weather: against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne…

Family

Application10/027,273Parent of this continuation · filed 21 Dec 2001

Application10/425,054Parent of this continuation · filed 28 Apr 2003

Application10/669,051Parent of this continuation · filed 23 Sep 2003

US 2004/0132762 A1Pre-grant publication · published 8 Jul 2004

US 6,677,349 B1Parent of this continuation

US 2004/0106638 A1Published application

US 6,924,293 B2Related patent

US 6,888,000 B2This patent

From the US filing history. Foreign family members aren’t listed.

Sulfonamide and sulfamide substituted imidazoquinolines

Life of this patent

Abstract

Claims1

Sulfonamide and sulfamide substituted imidazoquinolines

Life of this patent

Abstract

Claims1